BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3020729)

  • 1. [Mechanisms of hypertension in patients with terminal kidney failure on programmed hemodialysis].
    Krimkevich EI; Petrun' NM; Baran EIa; Kutsaĭ NN; Khomenko NV
    Ter Arkh; 1986; 58(8):81-4. PubMed ID: 3020729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency].
    Novo S; Adamo L; Forte G; Galfano G; Giamporcaro A; Ferrara D; Strano A
    Cardiologia; 1985 Jul; 30(7):505-10. PubMed ID: 3011264
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 7. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
    Hory B; Henriet MT
    Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mechanisms of the development of arterial hypertension in patients with chronic kidney failure treated by hemodialysis].
    Konstantinov IuV; Komandenko MS; Nikolaeva AA; D'iachuk MM
    Urol Nefrol (Mosk); 1993; (3):39-41. PubMed ID: 7941161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of controlled and uncontrolled arterial hypertension in patients with terminal kidney failure on chronic hemodialysis].
    Milovanova LIu; Nikolaev AIu; Lifshits NL; Milovanov IuS
    Ter Arkh; 2002; 74(6):45-9. PubMed ID: 12136483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sodium metabolism, plasma renin activity and arterial pressure in patients treated with periodic hemodialysis].
    Botey A; Mirapeix E; Rivera F; Cedo J; Revert L
    Rev Clin Esp; 1976 Jan; 140(1):59-66. PubMed ID: 1251055
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of hemodialysis on plasma-renin activity in patients with terminal kidney insufficiency].
    Wiesen K; Küppers H; Schnurr E
    Med Welt; 1977 Jan; 28(3):101-2. PubMed ID: 840018
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertension in end-stage renal disease. The relationship between blood pressure, plasma renin, plasma renin substrate and exchangeable sodium in chronic hemodialysis patients.
    Kornerup HJ
    Acta Med Scand; 1976; 200(4):257-61. PubMed ID: 10715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis.
    Jankova T; Tchankova P; Nenov D
    Nephrol Dial Transplant; 1991; 6 Suppl 3():6-9. PubMed ID: 1663601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma aldosterone in patients with end stage kidney disease.
    Weidmann P; Lupu AN; Schroth P; Maxwell MH
    Proc Eur Dial Transplant Assoc; 1972; 9():147-53. PubMed ID: 4668907
    [No Abstract]   [Full Text] [Related]  

  • 15. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F; Zwahlen A; Favre H; Vallotton M
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma aldosterone during haemodialysis in patients with terminal renal failure].
    Schnurr E; Küppers H; Wiesen K; Grabensee B
    Dtsch Med Wochenschr; 1976 Jul; 101(30):1120, 1125-8. PubMed ID: 1278056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone response to angiotensin II in patients with terminal renal failure and after bilateral nephrectomy.
    Woods TJ; McCaa RE; Bower JD; McCaa CS
    Trans Am Soc Artif Intern Organs; 1974; 20A():154-60. PubMed ID: 4375328
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma-renin in acute and chronic kidney insufficiency and hemodialysis].
    Schröder E; Herms W; Wetzels E; Dume T; Grabensee B
    Dtsch Med Wochenschr; 1969 Oct; 94(44):2262-7. PubMed ID: 5350092
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tensional regulation of chronic renal insufficiency patients treated by hemodialysis. Roles in constrictive action of angiotensin and renin activity].
    Zech P; Sassard J; Moskvtchenko JF; Pozet N; Traeger J
    J Urol Nephrol (Paris); 1968 Dec; 74(12):970-6. PubMed ID: 4305947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.